Single answer
Is Aethlon Medical Inc (AEMD) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
No analyst target data available for this ticker.
Company snapshot
A quick overview of the business and its public profile.
Aethlon Medical Inc a medical technology company focuses on developing products to diagnose and treat life and organ threatening diseases in the United States The company develops Aethlon Hemopurifier a clinicalstage immunotherapeutic device that removes tumorderived exosomes and lifethreatening viruses from the human circulatory system including removal of COVID19 virus associated variants and related exosomes Aethlon Medical Inc has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer The company was founded in 1999 and is based in San Diego California
Website: https://www.aethlonmedical.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.14 and is down -0.0800 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.07. Cash flow to debt ratio: -3,462.91. Net profit margin: 0.00%. Inflation risk score: medium (0.60/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Aethlon Medical Inc is $4.6M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Aethlon Medical Inc, 2015-12-31 had a stock price of $1,018.50. If you invested back then, your return now would be a loss of $1,015.73 per share or 99.73%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.
No analyst target data available for this ticker.